Rudi Van Den Eynde
About this author

Rudi Van Den Eynde

Head of Thematic Global Equity Management

Rudi Van Den Eynde has been our Head of Thematic Global Equity since 2011.

His career started in 1987 in the euro bonds department of Dexia Bank Belgium. He spent 11 years with the company in a variety of roles including 4 years as a currency trader and later as an institutional portfolio manager.

In 1998 he joined Candriam as a senior equity fund manager, and became Head of thematic global equity in 2012.

Rudi holds a bachelor’s degree of Medicine from the University of Antwerp, Belgium.

Discover the latest articles by Rudi Van Den Eynde

Equities, Rudi Van Den Eynde

Artificial intelligence: a revolution is underway

Artificial intelligence (AI) is about to revolutionise the diagnosis, surveillance and treatment of several diseases. Driven by technological development and research progress, growth in the AI market will surge over the next decade. An explanation.
Q&A, Health Care, Rudi Van Den Eynde

Biotech investing: is there a doctor in the house?

Rudi Van den Eynde, Head of Thematic Global Equity at Candriam, answers investors’ questions about a sector where depth of specialist knowledge is a prerequisite to consistent stock selection success.
Oncology, Q&A, Rudi Van Den Eynde, Equities

Investing in oncology: forewarned is forearmed

Rudi Van Den Eynde, Head of Thematic Global Equity, & Servaas Michielssens Senior Biotechnology Analyst at Candriam, outline to investors the approach they have used to create & develop an investment strategy in the oncology sector

Find it fast

Get information faster with a single click

Get insights straight to your inbox